Raloxifene/SBE-β-CD Inclusion Complexes Formulated into Nanoparticles with Chitosan to Overcome the Absorption Barrier for Bioavailability Enhancement

Raloxifene (RXF) is a hormone-like medication used for treating postmenopausal osteoporosis and estrogen-dependent breast cancer, yet associated with bad low bioavailability due to poor solubility. This study was intended to develop cyclodextrin/chitosan nanoparticles (ccNPs) for oral delivery of RX...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zaihua Wang, Yan Li
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2018-06-01
Colecção:Pharmaceutics
Assuntos:
raloxifene
bioavailability
nanoparticles
cyclodextrin
chitosan
electrostatic complexation
Acesso em linha:http://www.mdpi.com/1999-4923/10/3/76
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados